Trials / Recruiting
RecruitingNCT06637462
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
DISCRN in Rectal Cancer: DISseCting Response to Neoadjuvant Therapy in Rectal Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to learn more about how the body responds to standard treatment (chemoradiation and chemotherapy). The study will use the results of testing down on participants' blook, tissue, and scans to learn more about how people with rectal cancer respond to chemoradiation and chemotherapy treatment and if it is useful for predicting whether a person's cancer get better, gets worse, or stats the same after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Endoscopy | Standard of care endoscopy |
Timeline
- Start date
- 2024-10-09
- Primary completion
- 2027-10-09
- Completion
- 2027-10-09
- First posted
- 2024-10-15
- Last updated
- 2026-03-18
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06637462. Inclusion in this directory is not an endorsement.